Literature DB >> 7669744

BCL6 encodes a sequence-specific DNA-binding protein.

B W Baron1, R R Stanger, E Hume, A Sadhu, R Mick, J P Kerckaert, C Deweindt, C Bastard, G Nucifora, N Zeleznik-Le.   

Abstract

Chromosomal rearrangements of BCL6 are commonly associated with diffuse large-cell lymphomas. We set out to determine the DNA-binding site of a glutathione-S-transferase fusion protein containing the BCL6 zinc finger region by employing cyclic amplification and selection of targets (CASTing). From oligonucleotides containing 16 central random bases, sequences binding to the protein on glutathione-coated beads were repeatedly selected and amplified by polymerase chain reaction (PCR). The binding sites were cloned and sequenced. A consensus, TTTNNNGNNATNCTTT, was obtained. Protein binding studies of double-stranded oligomers containing point mutations within the 3' CTTT confirmed the binding specificity of this part of the consensus. In addition, evidence indicated that some of the base pairs held constant in the oligonucleotides used for CASTing also contributed to binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669744     DOI: 10.1002/gcc.2870130314

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.

Authors:  C C Chang; B H Ye; R S Chaganti; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Switching to BCL-6 Negativity in Relapsed Diffuse Large B Cell Lymphoma Correlated with More Aggressive Disease Course.

Authors:  Milena Todorović; Bela Balint; Bosko Andjelic; Ziv Radisavljevic; Biljana Mihaljevic
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-02       Impact factor: 0.900

3.  The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.

Authors:  Beverly W Baron; John Anastasi; Michael J Thirman; Yoichi Furukawa; Scott Fears; David C Kim; Federico Simone; Mark Birkenbach; Anthony Montag; Annamma Sadhu; Nancy Zeleznik-Le; Timothy W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

4.  Disruption of the Bcl6 gene results in an impaired germinal center formation.

Authors:  T Fukuda; T Yoshida; S Okada; M Hatano; T Miki; K Ishibashi; S Okabe; H Koseki; S Hirosawa; M Taniguchi; N Miyasaka; T Tokuhisa
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

5.  BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.

Authors:  Stella M Ranuncolo; Jose M Polo; Ari Melnick
Journal:  Blood Cells Mol Dis       Date:  2008-03-17       Impact factor: 3.039

6.  Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.

Authors:  Grace Lin; Christopher R LaPensee; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Cell Endocrinol       Date:  2014-08-01       Impact factor: 4.102

7.  Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas.

Authors:  Beverly W Baron; Nancy Zeleznik-Le; Miriam J Baron; Catherine Theisler; Dezheng Huo; Matthew D Krasowski; Michael J Thirman; Rebecca M Baron; Joseph M Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-27       Impact factor: 11.205

8.  BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.

Authors:  S Okabe; T Fukuda; K Ishibashi; S Kojima; S Okada; M Hatano; M Ebara; H Saisho; T Tokuhisa
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

9.  Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma.

Authors:  Michael R Green; Carolina Vicente-Dueñas; Isabel Romero-Camarero; Chih Long Liu; Bo Dai; Inés González-Herrero; Idoia García-Ramírez; Esther Alonso-Escudero; Javeed Iqbal; Wing C Chan; Elena Campos-Sanchez; Alberto Orfao; Belén Pintado; Teresa Flores; Oscar Blanco; Rafael Jiménez; Jose Angel Martínez-Climent; Francisco Javier García Criado; María Begoña García Cenador; Shuchun Zhao; Yasodha Natkunam; Izidore S Lossos; Ravindra Majeti; Ari Melnick; César Cobaleda; Ash A Alizadeh; Isidro Sánchez-García
Journal:  Nat Commun       Date:  2014-06-02       Impact factor: 14.919

10.  Role of the Transcriptional Repressor BCL6 in Allergic Response and Inflammation.

Authors:  Masafumi Arima; Takeshi Fukuda; Takeshi Tokuhisa
Journal:  World Allergy Organ J       Date:  2008-07       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.